Improving the bioavailability of nintedanib by formulating inhalable ufasomes as a targeted therapy for non-small cell lung cancer
通过将尼达尼布制成可吸入的ufasomes制剂,提高其生物利用度,作为非小细胞肺癌的靶向治疗药物
期刊:International Journal of Pharmaceutics: X
影响因子:6.4
doi:10.1016/j.ijpx.2025.100482
Ghazwani, Salman M; Alhazmi, Sami; Ghazwani, Salhah M; Shubaily, Hussam M; Wafi, Ahmed M; Alenazi, Naifa; Qadri, Marwa; Alshammari, Amal Naif; Mawkili, Wedad; Moshi, Jobran M; Khired, Zenat; Salama, Salama A